157 related articles for article (PubMed ID: 9445185)
21. The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma.
Mense ES; Smit AAJ; Crul M; Franssen EJF
J Clin Pharm Ther; 2019 Apr; 44(2):249-257. PubMed ID: 30578577
[TBL] [Abstract][Full Text] [Related]
22. Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN).
Chan Wah Hak C; Coyle C; Kocache A; Short D; Sarwar N; Seckl MJ; Gonzalez MA
BMC Cancer; 2019 Aug; 19(1):770. PubMed ID: 31382912
[TBL] [Abstract][Full Text] [Related]
23. [Multi-center randomized clinical study on Shenqi-fuzheng injection combined with chemotherapy in the treatment for lung cancer].
Lin HS; Li DR
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):931-4. PubMed ID: 18478934
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer.
Ando Y; Minami H; Saka H; Ando M; Sakai S; Shimokata K
Jpn J Cancer Res; 1996 Feb; 87(2):200-5. PubMed ID: 8609070
[TBL] [Abstract][Full Text] [Related]
25. [A case of small cell lung cancer with dermatomyositis that deteriorated with leukocytopenia due to chemotherapy].
Numata T; Kawabata A; Fujita Y; Bono K; Tamura K; Mikami J; Wakui H; Ito S; Yumino Y; Kawaishi M; Kuwano K
Nihon Kokyuki Gakkai Zasshi; 2008 Dec; 46(12):1059-64. PubMed ID: 19195212
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view.
Fazio N; Spada F; Giovannini M
Cancer Treat Rev; 2013 May; 39(3):270-4. PubMed ID: 22819619
[TBL] [Abstract][Full Text] [Related]
27. Fatal cisplatin overdose in the treatment of mediastinal lymphoma with the ESHAP regimen - analysis of the causes of the adverse drug event.
Jurek T; Rorat M; Dys P; Swiatek B
Onkologie; 2013; 36(1-2):49-52. PubMed ID: 23429332
[TBL] [Abstract][Full Text] [Related]
28. Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study.
Oka T; Kimura T; Suzumura T; Yoshimoto N; Nakai T; Yamamoto N; Matsuura K; Mitsuoka S; Yoshimura N; Kudoh S; Hirata K
BMC Pharmacol Toxicol; 2014 Dec; 15():70. PubMed ID: 25472655
[TBL] [Abstract][Full Text] [Related]
29. Flagellate erythema secondary to bleomycin.
Khaliq W; Antonarakis ES
QJM; 2012 Sep; 105(9):901. PubMed ID: 21865305
[No Abstract] [Full Text] [Related]
30. Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma.
Ikeda M; Okuyama H; Takahashi H; Ohno I; Shimizu S; Mitsunaga S; Kondo S; Morizane C; Ueno H; Okusaka T
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):623-7. PubMed ID: 25755102
[TBL] [Abstract][Full Text] [Related]
31. First-line cisplatin plus etoposide in high-grade metastatic neuroendocrine tumors of colon and rectum (MCRC NET): review of 8 cases.
Patta A; Fakih M
Anticancer Res; 2011 Mar; 31(3):975-8. PubMed ID: 21498724
[TBL] [Abstract][Full Text] [Related]
32. Metyrapone: a management option for ectopic ACTH syndrome in small cell lung cancer treated with intravenous etoposide.
Aziz SI; Khattak MA; Usmani Z; Ladipeerla N; Pittman K
BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22687664
[TBL] [Abstract][Full Text] [Related]
33. Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors.
Pajtler KW; Tippelt S; Siegler N; Reichling S; Zimmermann M; Mikasch R; Bode U; Gnekow A; Pietsch T; Benesch M; Rutkowski S; Fleischhack G
J Neurooncol; 2016 Jul; 128(3):463-71. PubMed ID: 27147083
[TBL] [Abstract][Full Text] [Related]
34. Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis.
Chen IC; Lin CH; Jan IS; Cheng AL; Lu YS
J Formos Med Assoc; 2016 Apr; 115(4):243-8. PubMed ID: 25890495
[TBL] [Abstract][Full Text] [Related]
35. Nimotuzumab treatment and outcome analysis in patients with leptomeningeal metastasis from nonsmall cell lung cancer.
Ju Y; Wang J; Sun S; Jiao S
J Cancer Res Ther; 2016 Dec; 12(Supplement):C181-C185. PubMed ID: 28230014
[TBL] [Abstract][Full Text] [Related]
36. Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life.
Fujisawa D; Temel JS; Traeger L; Greer JA; Lennes IT; Mimura M; Pirl WF
Psychooncology; 2015 Dec; 24(12):1731-7. PubMed ID: 25959002
[TBL] [Abstract][Full Text] [Related]
37. How many cisplatin administration protocols does your department use?
Greystoke AP; Jodrell DI; Cheung M; Rivans I; Mackean MJ
Eur J Cancer Care (Engl); 2010 Jan; 19(1):80-90. PubMed ID: 19708939
[TBL] [Abstract][Full Text] [Related]
38. [Alterations in tears aqueous layer during cytostatics treatment].
Wojciechowska K; Wieckowska-Szakiel M; Rózalska B; Jurowski P
Klin Oczna; 2013; 115(2):115-20. PubMed ID: 24059026
[TBL] [Abstract][Full Text] [Related]
39. Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells.
Teixeira SF; Guimarães Idos S; Madeira KP; Daltoé RD; Silva IV; Rangel LB
J Bras Pneumol; 2013; 39(6):644-9. PubMed ID: 24473757
[TBL] [Abstract][Full Text] [Related]
40. Probable etoposide interaction with Echinacea.
Bossaer JB; Odle BL
J Diet Suppl; 2012 Jun; 9(2):90-5. PubMed ID: 22607644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
